Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Dermoscopic Study of Intralesional Injection of Acyclovir Versus Candida Antigen in Treatment of Plantar Warts

NCT05429151 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT05429151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05429151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Dermoscopic Study of Intralesional Injection of Acyclovir Versus Candida Antigen in Treatment of Plantar Warts
Lead sponsor
Sohag University
Phase
Phase 4
Overall status
Unknown status
Start date
June 13, 2022
Completion date
May 1, 2023
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acyclovir and candida antigen in treatment of plantar wart